UK Markets closed

Biophytis SA (BPTS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.40-0.11 (-1.29%)
At close: 9:30AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.51
Open8.40
Bid8.47 x 900
Ask11.00 x 900
Day's range8.52 - 8.52
52-week range8.40 - 18.50
Volume44
Avg. volume2,287
Market cap95.583M
Beta (5Y monthly)1.13
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Globe Newswire

    Judgment Rendered on July 16, 2021 in the Proceedings Between Biophytis and Negma Group Ltd by the Execution Judge From the Paris Court of Justice

    PARIS and CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces that the judge in charge of overseeing

  • Globe Newswire

    Biophytis Presents Positive Preclinical Data on Sarconeos (BIO101) in COVID-19 at ECCMID 2021

    PARIS and CAMBRIDGE, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19 today announces new positive p

  • Globe Newswire

    Biophytis Reinforces Leadership Teams with Three Senior Appointments

    Claude Allary to be member of Board of Directors Benoit Canolle is appointed Chief Business OfficerJean Mariani, Chairman of Biophytis Scientific Committee to take over the Chief Medical Officer role PARIS and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associate